申请人:SMITHKLINE BEECHAM CORP
公开号:WO2005077918A1
公开(公告)日:2005-08-25
This invention relates to uracil-derived compounds of forumlas(I) and (II) which are agonists of the parathyroid hormone type I receptor (PTH1R) and as such are useful for the treament of osteoporosis.
这项发明涉及到式(I)和(II)的尿嘧啶衍生物,这些衍生物是甲状旁腺激素类型I受体(PTH1R)的激动剂,因此对于骨质疏松症的治疗是有用的。